Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Investigation|May 15, 2023
Prostate organoids: emerging experimental tools for translational researchMichael Beshiri, Supreet Agarwal, Juan Juan Yin, et al.
Omics : a Journal of Integrative Biology|March 10, 2012
Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomicsMahfoud Assem, Zita Sibenaller, Supreet Agarwal, et al.
Plos One|October 22, 2013
NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFRMohammad A Y Alqudah, Supreet Agarwal, Maha S Al-Keilani, et al.
Plos One|May 23, 2013
Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in gliomaSupreet Agarwal, Maha S Al-Keilani, Mohammad A Y Alqudah, et al.
Oncotarget|November 5, 2017
Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancerHong Pan, Keith H Jansson, Michael L Beshiri, et al.
Oncogene|July 18, 2019
EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasisLechen Li, Amir H Ameri, Simeng Wang, et al.
Molecular Cancer Therapeutics|May 7, 2020
Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid ReceptorRemi Adelaiye-Ogala, Berkley E Gryder, Yen Thi Minh Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2018
A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic ScreeningMichael L Beshiri, Caitlin M Tice, Crystal Tran, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Discover Oncology|October 1, 2022
Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2ANichelle C Whitlock, Margaret E White, Brian J Capaldo, et al.
Pageof 2